Lipid Nanoparticles Explained: Structure & mRNA Vaccine Mechanism

Added:

LNP Purpose
Charge Barrier
LNP Structure
Lipid Components
PEG Function
Cell Targeting
Endocytosis Process
Endosomal Escape
mRNA Release

LNP Purpose

0:01
Playing Section
  • 1

    Explains why mRNA vaccines need lipid nanoparticles for delivery.

  • 2

    Naked mRNA is degraded by enzymes and cannot cross cell membranes.

  • 3

    LNPs protect and transport mRNA into cells for protein production.

Basic structure and function of messenger RNA (mRNA) and the central dogma of molecular biology (transcription and translation).
Cell membrane composition, specifically the lipid bilayer and the behavior of amphipathic molecules in aqueous environments.
The cellular process of endocytosis, by which eukaryotic cells internalize extracellular substances.
Fundamental concepts of immunology, including how foreign proteins (antigens) trigger antibody production and T-cell responses.
The organic chemistry of ionizable lipids and how pH-dependent protonation triggers endosomal escape.
Advanced therapeutic applications of lipid nanoparticles (LNPs) beyond vaccines, such as CRISPR/Cas9 gene-editing delivery and oncology therapeutics.
The engineering of target-ligand conjugated LNPs for tissue-specific or organ-specific drug delivery (targeted nanomedicines).
Microfluidic assembly techniques and formulation challenges associated with the scale-up and stability of nanomedicines.
31.3K views691likes17:03@MedicoVisualOriginal Release: 2021-02-11

Lipid nanoparticles (LNPs) are nanoscale lipid-based carriers that enable mRNA vaccines to work by solving two critical problems: (1) protecting the negatively charged mRNA from degradation by RNases in the extracellular environment, and (2) facilitating the entry of mRNA into cells. Since RNA's negative charge prevents it from crossing the lipid bilayer cell membrane, LNPs encapsulate the mRNA using ionizable cationic lipids that become positively charged at acidic pH during vaccine production to bind with the RNA, then become neutral at physiological pH. The LNP structure includes helper lipids (phospholipids, cholesterol) for stability and PEGylated lipids that prevent premature immune clearance. Upon cellular uptake via endocytosis, the acidic endosomal environment causes the ionizable lipids to regain positive charge, triggering fusion with the endosomal membrane and releasing the mRNA into the cytoplasm for translation.